Mortality After Rasburicase vs. Allopurinol Anti-Hyperuricemia Monotherapy in Patients With Liquid Tumors
Author Type(s)
Faculty
Document Type
Abstract
Publication Date
10-2023
DOI
10.1016/j.annonc.2023.09.711
Journal Title
Annals of Oncology
Department
Pediatrics
Recommended Citation
Cairo, M. S., Gallagher, J. R., Drea, E. J., Barnes, Y. J., Clark, C., & Carroll, S. (2023). Mortality After Rasburicase vs. Allopurinol Anti-Hyperuricemia Monotherapy in Patients With Liquid Tumors. Annals of Oncology, 34 (Suppl.2), S551-S552. https://doi.org/10.1016/j.annonc.2023.09.711
COinS
